Avaleht › 1. tüüpi diabeet › Washington › Seattle
1. tüüpi diabeet kliinilised uuringud linnas Seattle, WA
18 uuringut haiguse 1. tüüpi diabeet jaoks otsivad osalejaid linnas Seattle ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
Type 1 Diabetes Extension Study
VärbamineVaatlusuuring
- Benaroya Research Institute, Seattle
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
VärbamineFaas 2
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
VärbamineFaas 3
- Benaroya Research Institute at Virginia Mason- Site Number : 8400038, Seattle
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
VärbamineFaas 1/2
- Benaroya Research Institute, Seattle
- University of Washington Diabetes Institute, Seattle
Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
VärbamineFaas 2
- Benaroya Research Institute, Seattle
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
VärbamineFaas 2
- Benaroya Research Institute, Seattle
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
VärbamineFaas 1/2
- Seattle Children's Hospital, Seattle
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
VärbamineFaas 2
- Benaroya Research Institute at Virginia Mason, Seattle
Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
Värbamine
- University of Washington, Seattle
Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
VärbamineFaas 2
- University of Washington, Seattle
Kidney Precision Medicine Project
VärbamineVaatlusuuring
- University of Washington, Seattle
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
VärbamineFaas 3
- University of Washington, Seattle
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
VärbamineFaas 3
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.
Värbamine
- Seattle Children's, Seattle
EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
VärbamineVaatlusuuring
- Benaroya Research Institute, Seattle
InvesT1D: Promoting Adolescent Investment in Diabetes Care
Värbamine
- Seattle Children's, Seattle
TrialNet Pathway to Prevention of T1D
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
- Benaroya Research Institute, Seattle
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
VärbamineFaas 1
- Seattle Children's Hospital, Seattle
1. tüüpi diabeet uuringud teistes linnades
- Aurora, CO23 uuringut
- Boston, MA21 uuringut
- Chicago, IL16 uuringut
- New Haven, CT15 uuringut
- New York City, NY15 uuringut
- Indianapolis, IN14 uuringut
- San Francisco, CA14 uuringut
- Miami, FL13 uuringut
- Gainesville, FL12 uuringut
- Philadelphia, PA11 uuringut
- Atlanta, GA11 uuringut
- Durham, NC10 uuringut
Muud uuringud linnas Seattle
- Mitteväikerakuline kopsuvähk53 uuringut
- Vähk (kõik liigid)49 uuringut
- Eesnäärmevähk42 uuringut
- Äge müeloidne leukeemia40 uuringut
- Rinnavähk39 uuringut
- Metastaatiline vähk39 uuringut
- Käär- ja pärasoolevähk34 uuringut
- Kopsuvähk33 uuringut
- Munasarjavähk30 uuringut
- Müeloom22 uuringut
- Müelodüsplastilised sündroomid21 uuringut
- Äge lümfoblastne leukeemia21 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.